title: A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators.
abstract: Concern about risks of allogeneic transfusion has led to an interest in methods for decreasing perioperative transfusion. To determine whether cell salvage reduces patient exposure to allogeneic blood, we performed meta-analyses of randomized trials, evaluating the effectiveness and safety of cell salvage in cardiac or orthopedic elective surgery. The primary outcome was the proportion of patients who received at least one perioperative allogeneic red cell transfusion. Twenty-seven studies were included in the meta-analyses. Cell salvage devices that do not wash salvaged blood were marginally effective in cardiac surgery patients when used postoperatively (relative risk [RR] = 0.85, 95% confidence interval [CI] = 0.79-0.92). Devices that wash or do not wash salvaged blood considerably decreased the proportion of orthopedic surgery patients who received allogeneic transfusion (RR = 0.39, 95% CI = 0.30-0.51 and RR = 0.35, 95% CI 0.26-0.46, respectively). No studies of cell savers that wash salvaged blood during cardiac surgery were included. Cell salvage did not appear to increase the frequency of adverse events. We conclude that cell salvage in orthopedic surgery decreases the risk of patients' exposure to allogeneic blood transfusion perioperatively. Postoperative cell salvage in cardiac surgery, with devices that do not wash the salvaged blood, is only marginally effective.
  
  
  CONCLUSIONS
  This meta-analysis of all published randomized trials provides the best current estimate of the effectiveness of cell salvage and is useful in guiding clinical practice. We conclude that cell salvage in orthopedic surgery decreases the proportion of patients requiring allogeneic blood transfusion perioperatively, but postoperative cell salvage is only marginally effective in cardiac surgery.
authors.affiliation: INSERM U-330, Université Victor Segalen Bordeaux, France.
authors.forename: C
authors.initials: C
authors.lastname: Huët
authors.forename: L R
authors.initials: LR
authors.lastname: Salmi
authors.forename: D
authors.initials: D
authors.lastname: Fergusson
authors.forename: A W
authors.initials: AW
authors.lastname: Koopman-van Gemert
authors.forename: F
authors.initials: F
authors.lastname: Rubens
authors.forename: A
authors.initials: A
authors.lastname: Laupacis
mesh_terms: D001803:Blood Transfusion; D001804:Blood Transfusion, Autologous; D006348:Cardiac Surgical Procedures; D016001:Confidence Intervals; D017558:Elective Surgical Procedures; D017707:Erythrocyte Transfusion; D006801:Humans; D007430:Intraoperative Care; D016017:Odds Ratio; D019637:Orthopedic Procedures; D017063:Outcome Assessment, Health Care; D019990:Perioperative Care; D011182:Postoperative Care; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012449:Safety; D014184:Transplantation, Homologous